Venmax Drugs & Pharmaceuticals Ltd is engaged in the business of IT & ITES servicesBusiness Overview: a) VDPL is focused on establishing chain of Medical Stores with a brand name Ananya Pharma under the Venmax Drugs & Pharma Ltd, with the backing support of Formulations plant (Suzichem Labs). Currently, it...
Venmax Drugs & Pharmaceuticals Limited has published newspaper advertisements detailing its financial results for the quarter ended June 30, 2026. These advertisements appeared in "Financial Express" and "Nava Telangana," ensuring broad public dissemination. This action provides crucial access for shareholders and potential investors to the company's latest quarterly performance data....
Venmax Drugs & Pharmaceuticals confirmed no deviation in using funds from its preferential issue. The company stated that Rs. 8.37 crore was utilized for working capital and Rs. 0.20 crore for general corporate purposes and business acquisition, out of the total Rs. 20.05 crore planned. A total of Rs. 12.69...
The company has allotted 7,53,334 new equity shares to a non-promoter warrant holder upon conversion. These shares were issued at Rs. 20 each, bringing in an additional 1.13 Cr as the balance exercise price. This boosts the company's paid-up capital to 14.48 Cr, now comprising 1.45 Cr shares. Investors should...
The company has allotted 21.47 lakh new equity shares to eight non-promoter warrant holders who exercised their conversion rights at Rs. 20 each. This transaction generated Rs. 3.22 Cr for the company. Consequently, the paid-up capital has increased to Rs. 13.73 Cr, now comprising 1.37 Cr equity shares. This capital...
Venmax Drugs & Pharmaceuticals has confirmed compliance by submitting a certificate from its Registrar and Share Transfer Agent, CIL Securities Limited. This document attests to the company's adherence to required procedures for handling investor shares and dematerialization requests for the quarter ended June 30. This process is crucial for maintaining...
